Lifestyle

Laurel Road: How Some States Are Taking Action on Student Loan Forgiveness

Laurel Road: How Some States Are Taking Action on Student Loan Forgiveness


NEW YORK, June 12, 2023 (Newswire.com)
–
Laurel Road: Student loan debt is a major issue for Americans, with tens of millions of borrowers owing a staggering $1.76 trillion in federal and private student loan debt as of December 2022. Many struggle to pay off their debt, including recent graduates who might still be searching for steady employment.

Federal student loan borrowers may be able to pursue loan forgiveness through income-driven repayment plans or the Public Service Loan Forgiveness program, if they’re eligible. In addition, some individual states offer their own loan forgiveness programs that may prove helpful to qualified borrowers. In fact, the only state without any student loan forgiveness option is North Dakota, which removed its program in 2019. Here are four of the state governments that are taking action on student loan forgiveness, and some examples of the programs available:

Minnesota

Minnesota is one of the leading states in terms of student loan forgiveness programs, with six programs available to its residents. One such plan is the Minnesota Rural Physician Loan Forgiveness Program for healthcare professionals, which offers up to $33,000/year for four years if they work in underserved areas and facilities in the state. There are also loans for other medical professionals, such as nurses, pharmacists, and dentists, and a program for lawyers who work in the public interest and who graduated law from a qualifying school.

New York 

New York offers varying amounts of student loan forgiveness to professionals in different fields, including healthcare workers, lawyers, and teachers. For example, the Young Farmers Loan Forgiveness Incentive Program encourages recent graduates to pursue farming careers in the state. This program provides up to $50,000 in forgiveness to borrowers who obtain a degree from an approved college or university and agree to operate a full-time farm in New York for five years. 

Another potential option is the NYS Licensed Social Worker Loan Forgiveness Program, which offers an incentive to increase the number of licensed social workers working in critical human service areas, such as home care, mental health, substance abuse, and more. The program provides up to $26,000 for those who qualify. 

Iowa 

Iowa offers its residents six student loan forgiveness programs, including Teach Iowa Scholars, which provides up to $4,000/year of loan forgiveness for qualified teachers who work in schools in designated shortage areas for a maximum of five years.

The state also offers the Iowa Registered Nurse and Nurse Educator Loan Forgiveness Program, which provides loan forgiveness for registered nurses employed in Iowa and nurse educators teaching at eligible Iowa colleges and universities. And the Rural Iowa Primary Care Loan Repayment Program, created to address critical doctor shortages in rural communities, provides up to $200,000 in loan repayment to those that practice in approved locations for up to five years.

Arizona 

Arizona’s three programs include the Primary Care Provider Loan Repayment Program and Rural Private Primary Care Provider Loan Repayment Program. These offer forgiveness amounts between $4,000 and $65,000/year, depending on the area and how many years served. The program is meant to promote the recruitment and retention of healthcare professionals by repaying qualifying loans in exchange for providing primary care services in designated Health Professional Shortage Areas or Arizona Medically Underserved Areas for two years.

Arizona also offers the Joyce Holsey’s ALL (Arizona’s Legal Legacy) Loan Repayment Assistance Program, which provides varying amounts to Arizona legal aid attorneys employed by an approved nonprofit organization. 

State Programs for Forgiveness 

Student loan debt is a significant issue for millions of Americans, but some states are taking action to help residents tackle their debt. From offering loan forgiveness programs for healthcare professionals who work in underserved areas to providing repayment assistance to teachers in qualifying public schools after graduation, these states are making a difference in the lives of their residents. State programs constantly change on a state by state basis. For the most up to date information please visit your home state website to see what programs are currently available. 

References: 

https://www.federalreserve.gov/releases/g19/HIST/cc_hist_memo_levels.html  

https://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2023/03/13/as-supreme-court-considers-student-loan-forgiveness-states-may-expand-their-programs#:~:text=Every%20state%20but%20North%20Dakota%20has%20at%20least%20one%20loan%20forgiveness%20plan

https://thecollegeinvestor.com/student-loan-forgiveness-programs-by-state

Individual state government websites

Contact Information:

Carolina d’Arbelles-Valle

Senior Public Relations Specialist

[email protected]

(201) 633-2125

Original Source:

Laurel Road: How Some States Are Taking Action on Student Loan Forgiveness

Laurel Road: How Some States Are Taking Action on Student Loan Forgiveness

The post Laurel Road: How Some States Are Taking Action on Student Loan Forgiveness first appeared on RSVTV news.

Editor
Read More
Health News

Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post Covid Syndrome’

Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post Covid Syndrome’


GAINESVILLE, Fla., June 12, 2023 (Newswire.com)
–
Neobiosis, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of medicines. Today, Neobiosis announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for ViXome™, its drug for the treatment of ‘Post COVID Syndrome (AKA “Long Haul COVID Syndrome”).

“This is an important milestone for Neobiosis and we are excited to be advancing ViXome, a refined product extracted from thoroughly screened and sterile amniotic fluid obtained at the time of c-section of at-term pregnancies, into clinical development,” said Ian A. White, Ph.D., CEO and CSO of Neobiosis. “We are eager to confirm our preclinical data in the clinic and expect to begin enrolling patients in Phase 1 during the second quarter of 2024.”

ViXome, an acellular product derived from amniotic fluid, contains a heterogeneous population of growth factors, cytokines, chemokines, microRNAs and exosomes, which in pre-clinical testing has demonstrated potent immunomodulatory and pro-reparative effects.

The Phase I/IIa study will thoroughly investigate the safety and clinical efficacy of ViXome. Neobiosis products are processed in state-of-the-art, FDA-registered and FDA-inspected cGMP-compliant cleanrooms in Gainesville, FL. Neobiosis performs its research and development (R&D) at the University of Florida (UF) Sid Martin Innovate Biotechnology Institute in Alachua, FL., the world-recognized leader in biotechnology incubation.

“We are excited to be one of the first companies in the US to advance a potential therapeutic for the treatment of a devastating disease that already affects over 300 million people worldwide,” added Dr. White.

About Neobiosis 

Neobiosis is a clinical-stage biopharmaceutical company pioneering the development of perinatal tissue-derived therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical needs. By leveraging the biology of birth tissues as a natural source of regenerative and immunomodulatory cells, matrix and exosomes, Neobiosis has developed its proprietary platform to augment the innate properties of homeostasis to create a portfolio of novel therapeutic candidates. Neobiosis is dedicated to transparency, safety and efficacy of all of its products developed under FDA oversight.

Contact Information:

ian white

CEO

[email protected]

3059062345

Original Source:

Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post Covid Syndrome’

Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post Covid Syndrome’

Editor
Read More
Beauty Style News

Allan W. Koch Named Chief Financial Officer of the Hallstar Company

Allan W. Koch Named Chief Financial Officer of the Hallstar Company

Based in Hallstar’s Chicago headquarters, Allan will lead Hallstar’s global finance organization and all financial activities.


CHICAGO, June 12, 2023 (Newswire.com)
–
Hallstar, a leading global supplier of specialty chemistry, is pleased to announce the promotion of Allan Koch to chief financial officer. In this role, he will be responsible for Hallstar’s finance and accounting teams in all countries where the company operates, and will join the executive leadership team as a strategic advisor, reporting to the CEO and Chairman.

Chairman and CEO John Paro observed that this appointment is aligned with Hallstar’s passion for people. “Our first choice is always to develop our own talented team so their responsibilities can increase naturally within the company. Allan knows our operation, our people and our core values. His deep understanding of our global financial position coupled with his strong personal integrity and longstanding relationships at Hallstar will serve him well as he takes on this broader role.”

Having joined Hallstar in 2015 as the global controller and most recently serving as treasurer, Koch brings a wealth of experience to his new position. Prior to joining Hallstar, he held progressive roles at networking solutions provider CommScope, where he served as the Director of North America’s accounting organization, supporting a >$1B business. Additionally, Allan led the finance function in multiple global locations at CommScope, including high-profile tenures in Mexico and India where both operations experienced remarkable growth.

During his impactful eight-year tenure at Hallstar, Allan has played a pivotal role in driving several transformative projects. He cites collaborating with his teammates on the successful SAP/ERP integration as a highlight. He was also instrumental in the reorganization of the company into two distinct commercial businesses, namely Beauty & Personal Care and Industrial Solutions, supported by a Shared Services group.

In addition to his prowess as a financial leader, Koch is an enthusiastic participant in many of Hallstar’s outreach and training initiatives, including the annual Run/Walk benefitting Wellness House, an organization providing cancer support to the Chicagoland community. In 2021, he was selected to join the first cohort of senior staff members enrolled in the Hallstar Leadership Institute. Subsequently, he was invited to present on the topic of servant leadership to trainees in the same program the following year.

After receiving his BBA in Accounting from University of Wisconsin-Madison, Koch earned an MBA from Northwestern’s Kellogg School of Management. He currently lives in the western suburbs of Chicago with his wife and their two children. 

“I am humbled by the opportunity to join the Senior Leadership Team, where I will have the opportunity to collaborate with talented professionals across the organization,” said Koch. “Together, we will navigate challenges and seize opportunities to further strengthen Hallstar’s financial performance and create long-term value.”

Contact Information:

Marie Paro

[email protected]

Original Source:

Allan W. Koch Named Chief Financial Officer of the Hallstar Company

The post Allan W. Koch Named Chief Financial Officer of the Hallstar Company first appeared on NT Beauty.

Editor
Read More